ABL Bio (Korea) Analysis

ABL Stock Analysis Notes

About 32.0% of the company shares are owned by insiders or employees . The company had not issued any dividends in recent years. ABL Bio Inc., a biotech research company, focuses on the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases. Its pipeline drugs include ABL001, cancer immunotherapy, ADC, and ABL301. ABL Bio is traded on Korean Securities Dealers Automated Quotations in South Korea. For more info on ABL Bio please contact Sang Lee at 82 31 8018 9800 or go to http://www.ablbio.com.

ABL Bio Investment Alerts

ABL Market Capitalization

The company currently falls under 'Mega-Cap' category with a current market capitalization of 958.17 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate ABL Bio's market, we take the total number of its shares issued and multiply it by ABL Bio's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Technical Drivers

As of the 2nd of February, ABL Bio shows the Coefficient Of Variation of 67792.83, mean deviation of 3.33, and Downside Deviation of 3.9. ABL Bio technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the entity's future prices.

ABL Bio Price Movement Analysis

ABL Bio Outstanding Bonds

ABL Bio Predictive Daily Indicators

ABL Bio Forecast Models

ABL Bio's time-series forecasting models are one of many ABL Bio's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary ABL Bio's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how ABL Bio prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling ABL shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as ABL Bio. By using and applying ABL Stock analysis, traders can create a robust methodology for identifying ABL entry and exit points for their positions.

When running ABL Bio's price analysis, check to measure ABL Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ABL Bio is operating at the current time. Most of ABL Bio's value examination focuses on studying past and present price action to predict the probability of ABL Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ABL Bio's price. Additionally, you may evaluate how the addition of ABL Bio to your portfolios can decrease your overall portfolio volatility.